Metabolic dysfunction-associated steatotic liver disease (MASLD) is an unabated risk factor
for end-stage liver diseases with no available therapies. Dysregulated immune responses …

Insulin resistance is the main mechanism in a whole series of pathological conditions, which
are not only of metabolic interest but also of a systemic type. This phenomenon means that …

Non-alcoholic fatty liver disease (NAFLD) causes significant global disease burden and is a
leading cause of mortality. NAFLD induces a myriad of aberrant changes in hepatocytes at …

The association between obstructive sleep apnea (OSA) and metabolic disorders is well-
established; however, the underlying mechanisms that elucidate this relationship remain …

Metabolic dysfunction-associated steatotic liver disease (MASLD) remains the most common
cause of liver disease in the United States due to the increased incidence of metabolic …

Metabolic dysfunction-associated steatohepatitis (MASH) is the replacement term for what
used to be called nonalcoholic steatohepatitis (NASH). It is characterized by inflammation …

Abstract Non-alcoholic steatohepatitis (NASH), caused by fat buildup, can lead to liver
inflammation and damage. Elucidation of the spatial distribution of fibrotic tissue in the fatty …

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of
nonalcoholic fatty liver disease characterised by fat accumulation, inflammation, oxidative …

Metabolic Dysfunction-Associated Steatotic Liver (MASL), previously named nonalcoholic
fatty liver (NAFL), is a multifactorial disease in which metabolic, genetic, and environmental …

Hypertriglyceridemia is a common cause of acute pancreatitis (AP). Fatty liver, a
manifestation of metabolic syndrome, is related to the severity of AP. The present study …